Health ❯Medicine ❯Clinical Trials

Drug Trials

Lorlatinib Ketamine Phase Two Trials

Ketamine Shows Promise for Treatment-Resistant Depression in Clinical Trials

Pfizer's Lorbrena Sets New Benchmark in Treating Advanced Lung Cancer

Diabetes Drug Lixisenatide Shows Promise in Slowing Parkinson's Progression